País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
CYPROTERONE ACETATE ETHINYLESTRADIOL
McDowell Pharmaceuticals
2mg/35mcg
Coated Tablets
2010-10-29
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dianette 2mg/35micrograms coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.0 mg cyproterone acetate and 0.035 mg ethinylestradiol. Excipients: Lactose monohydrate 31.115mg Sucrose 19.371mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated tablet (tablet). _Product imported from the UK:_ Beige, sugar-coated, biconvex tablets 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For use in the management of severe acne vulgaris, especially those forms which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica) in women. Oral contraception for the woman suffering from the above. Although Dianette also acts as an oral contraceptive, it should not be used in women solely for contraception, but should be reserved for those women requiring treatment for the androgen-dependent acne described. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION HOW TO TAKE DIANETTE Dianette is to be taken regularly in order to achieve the therapeutic efficacy and the required contraceptive protection. Combined oral contraceptives when taken correctly have a failure rate of approximately 1% per year. Tablets must be taken in the order directed on the package every day at about the same time with some liquid as needed. One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet- free interval, during which time a withdrawal bleed usually occurs. This usually starts on day 2-3 after the last tablet and may not have finished before the next pack is started. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Leer el documento completo